Daniel LeSueur, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 5,208 shares at $6.15 ($32K) on 2024-07-03, disclosed to the SEC on 2024-07-08.
Scheduled sale ($32k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HCAT | SELL | 2025-03-10 | $153K | — | Filing → |
| HCAT | SELL | 2025-02-06 | $30K | — | Filing → |
| HCAT | SELL | 2025-01-10 | $39K | — | Filing → |